BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 1572445)

  • 1. Effect of hyposensitization upon the immediate and late asthmatic reaction and upon histamine reactivity in patients allergic to house dust mite (Dermatophagoides pteronyssinus).
    Van Bever HP; Stevens WJ
    Eur Respir J; 1992 Mar; 5(3):318-22. PubMed ID: 1572445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of the late asthmatic reaction by hyposensitization in asthmatic children allergic to house dust mite (Dermatophagoides pteronyssinus) or grass pollen.
    Van Bever HP; Bosmans J; De Clerck LS; Stevens WJ
    Allergy; 1988 Jul; 43(5):378-85. PubMed ID: 3414914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of the late asthmatic reaction by hyposensitization in asthmatic children allergic to house dust mite (Dermatophagoides pteronyssinus).
    Van Bever HP; Stevens WJ
    Clin Exp Allergy; 1989 Jul; 19(4):399-404. PubMed ID: 2758353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of 1-year specific immunotherapy with standardized house dust mite vaccine on mild to moderate allergic asthmatic patients].
    Wang HY; Lin XP; Hao CL; Zhang CQ; Sun BQ; Zheng JP; Chen P; Sheng JY; Wu A; Zhong NS
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Oct; 29(10):679-87. PubMed ID: 17129496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Der p 1 and Der p 2 induce less severe late asthmatic responses than native Dermatophagoides pteronyssinus extract after a similar early asthmatic response.
    Van Der Veen MJ; Jansen HM; Aalberse RC; van der Zee JS
    Clin Exp Allergy; 2001 May; 31(5):705-14. PubMed ID: 11422129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of bronchial responsiveness to leukotrienes in antigen-induced immediate and late asthmatic response].
    Yamai T; Watanabe S; Motojima S; Numao T; Amagai M; Otsuka T; Toda M; Fukuda T; Makino S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Sep; 30(9):1687-94. PubMed ID: 1447845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The respiratory effects of reduction of mite allergen in the bedrooms of asthmatic children--a double-blind controlled trial.
    Carswell F; Birmingham K; Oliver J; Crewes A; Weeks J
    Clin Exp Allergy; 1996 Apr; 26(4):386-96. PubMed ID: 8732235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a bronchial provocation test with house-dust mite on blood eosinophilia, eosinophil cationic protein, soluble interleukin-2 receptor, and interleukin-6 in asthmatic children.
    Van Bever HP; Moens MM; Bridts CH; De Clerck LS; Mertens AV; Bosmans E; Stevens WJ
    Allergy; 1993 Aug; 48(6):443-9. PubMed ID: 8238800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
    Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
    Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of the late asthmatic reaction during immunotherapy and after stopping immunotherapy.
    Van Bever HP; Stevens WJ
    J Allergy Clin Immunol; 1990 Aug; 86(2):141-6. PubMed ID: 2384645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validated safety predictions of airway responses to house dust mite in asthma.
    Ravensberg AJ; van Rensen EL; Grootendorst DC; de Kluijver J; Diamant Z; Ricciardolo FL; Sterk PJ
    Clin Exp Allergy; 2007 Jan; 37(1):100-7. PubMed ID: 17210047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the long-term efficacy of 3- and 5-year house dust mite allergen immunotherapy.
    Stelmach I; Sobocińska A; Majak P; Smejda K; Jerzyńska J; Stelmach W
    Ann Allergy Asthma Immunol; 2012 Oct; 109(4):274-8. PubMed ID: 23010234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase in vesicular hand eczema after house dust mite inhalation provocation: a double-blind, placebo-controlled, cross-over study.
    Schuttelaar ML; Coenraads PJ; Huizinga J; De Monchy JG; Vermeulen KM
    Contact Dermatitis; 2013 Feb; 68(2):76-85. PubMed ID: 23046099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of anti-allergic mattress encasings on house dust mite-induced early- and late-airway reactions in asthmatic patients. A double-blind, placebo-controlled study.
    Rijssenbeek-Nouwens LH; Oosting AJ; De Monchy JG; Bregman I; Postma DS; De Bruin-Weller MS
    Clin Exp Allergy; 2002 Jan; 32(1):117-25. PubMed ID: 12002728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local immunotherapy by inhalation of a powder extract in asthma due to house dust mite Dermatophagoides pteronyssinus: a double-blind comparison with parenteral immunotherapy.
    Moscato G; Rossi G; Dellabianca A; Pisati A; Vinci G; Biale C
    J Investig Allergol Clin Immunol; 1991 Dec; 1(6):383-94. PubMed ID: 1669598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of specific immunotherapy added to pharmacologic treatment and allergen avoidance in asthmatic patients allergic to house dust mite.
    Maestrelli P; Zanolla L; Pozzan M; Fabbri LM;
    J Allergy Clin Immunol; 2004 Apr; 113(4):643-9. PubMed ID: 15100667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Frequency of sensitization to D. pteronyssinus or D. farinae in children with perennial bronchial asthma].
    Zimmermann T; Mayer J
    Monatsschr Kinderheilkd; 1985 Apr; 133(4):214-8. PubMed ID: 4000137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: a randomized, double-blind, placebo-controlled trial.
    Mosbech H; Deckelmann R; de Blay F; Pastorello EA; Trebas-Pietras E; Andres LP; Malcus I; Ljørring C; Canonica GW
    J Allergy Clin Immunol; 2014 Sep; 134(3):568-575.e7. PubMed ID: 24797423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The allergen specificity of the late asthmatic reaction.
    Hatzivlassiou M; Grainge C; Kehagia V; Lau L; Howarth PH
    Allergy; 2010 Mar; 65(3):355-8. PubMed ID: 19804443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective allergen avoidance at high altitude reduces allergen-induced bronchial hyperresponsiveness.
    Peroni DG; Boner AL; Vallone G; Antolini I; Warner JO
    Am J Respir Crit Care Med; 1994 Jun; 149(6):1442-6. PubMed ID: 8004296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.